Speciality Medi.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
246.45
41.05 (19.99%)
BSENSE

Apr 17

BSE+NSE Vol: 336000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 111.71% vs 18.43% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 73.16% vs 47.37% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -17.20% vs 73.95% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 193.43% vs 73.70% in Mar 2024

Compare Profit and Loss Results of Speciality Medi.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
58.00
115.00
-57.00
-49.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
58.00
115.00
-57.00
-49.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
3.00
-12.00
-400.00%
Raw Materials Consumed
51.00
49.00
2.00
4.08%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
2.00
14.00
-12.00
-85.71%
Operating Expenses
0.00
4.00
-4.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
2.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
49.00
88.00
-39.00
-44.32%
Operating Profit (PBDIT) excl Other Income
9.00
26.00
-17.00
-65.38%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
9.00
35.00
-26.00
-74.29%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
8.00
35.00
-27.00
-77.14%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
8.00
33.00
-25.00
-75.76%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
32.00
-24.00
-75.00%
Provision for Tax
0.00
8.00
-8.00
-100.00%
Profit After Tax
8.00
24.00
-16.00
-66.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
5.00
147.00
-142.00
-96.60%
Profit Available for appropriations
13.00
171.00
-158.00
-92.40%
Appropriations
13.00
171.00
-158.00
-92.40%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
14.1
67.61
-53.51
-79.15%
Profit And Loss - Net Sales
Net Sales 58.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 111.71% vs 18.43% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.13 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 73.16% vs 47.37% in Mar 2024

Profit And Loss - Interest
Interest 0.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.20% vs 73.95% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 8.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 193.43% vs 73.70% in Mar 2024